Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRβ-deficient mice
S. Alberti, … , S. Pettersson, J.-Å. Gustafsson
S. Alberti, … , S. Pettersson, J.-Å. Gustafsson
Published March 1, 2001
Citation Information: J Clin Invest. 2001;107(5):565-573. https://doi.org/10.1172/JCI9794.
View: Text | PDF
Article Article has an altmetric score of 9

Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRβ-deficient mice

  • Text
  • PDF
Abstract

The nuclear oxysterol-receptor paralogues LXRα and LXRβ share a high degree of amino acid identity and bind endogenous oxysterol ligands with similar affinities. While LXRα has been established as an important regulator of cholesterol catabolism in cholesterol-fed mice, little is known about the function of LXRβ in vivo. We have generated mouse lines with targeted disruptions of each of these LXR receptors and have compared their responses to dietary cholesterol. Serum and hepatic cholesterol levels and lipoprotein profiles of cholesterol-fed animals revealed no significant differences between LXRβ–/– and wild-type mice. Steady-state mRNA levels of 3-hydroxy-3-methylglutaryl coenzyme A reductase, farnesyl diphosphate synthase, and squalene synthase were increased in LXRβ–/– mice compared with LXRβ+/+ mice, when fed standard chow. The mRNA levels for cholesterol 7α-hydroxylase, oxysterol 7α-hydroxylase, sterol 12α-hydroxylase, and sterol 27-hydroxylase, respectively, were comparable in these strains, both on standard and 2% cholesterol chow. Our results indicate that LXRβ–/– mice — in contrast to LXRα–/– mice — maintain their resistance to dietary cholesterol, despite subtle effects on the expression of genes coding for enzymes involved in lipid metabolism. Thus, our data indicate that LXRβ has no complete overlapping function compared with LXRα in the liver.

Authors

S. Alberti, G. Schuster, P. Parini, D. Feltkamp, U. Diczfalusy, M. Rudling, B. Angelin, I. Björkhem, S. Pettersson, J.-Å. Gustafsson

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Total
Citations: 1 1 3 3 4 6 7 9 5 6 5 7 3 12 7 8 9 10 3 1 3 2 2 1 118
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2012 (12)

Title and authors Publication Year
Central diabetes insipidus associated with impaired renal aquaporin-1 expression in mice lacking liver X receptor β
C Gabbi, X Kong, H Suzuki, HJ Kim, M Gao, X Jia, H Ohnishi, Y Ueta, M Warner, Y Guan, JÅ Gustafsson
Proceedings of the National Academy of Sciences 2012
Liver X receptors and fat cell metabolism
J Laurencikiene, M Rydén
International Journal of Obesity 2012
Genome-wide landscape of liver X receptor chromatin binding and gene regulation in human macrophages
P Pehkonen, L Welter-Stahl, J Diwo, J Ryynänen, A Wienecke-Baldacchino, S Heikkinen, E Treuter, KR Steffensen, C Carlberg
BMC Genomics 2012
Anxiety in liver X receptor   knockout female mice with loss of glutamic acid decarboxylase in ventromedial prefrontal cortex
X Tan, Y Dai, W Wu, M Warner, JA Gustafsson
Proceedings of the National Academy of Sciences 2012
Therapy of Pelizaeus-Merzbacher disease in mice by feeding a cholesterol-enriched diet
G Saher, F Rudolphi, K Corthals, T Ruhwedel, KF Schmidt, S Löwel, P Dibaj, B Barrette, W Möbius, KA Nave
Nature Medicine 2012
Soy protein isoflavones differentially regulate liver X receptor isoforms to modulate lipid metabolism and cholesterol transport in the liver and intestine in mice
M González-Granillo, KR Steffensen, O Granados, N Torres, M Korach-André, V Ortíz, C Aguilar-Salinas, T Jakobsson, A Díaz-Villaseñor, A Loza-Valdes, R Hernandez-Pando, JÅ Gustafsson, AR Tovar
Diabetologia 2012
A role for protein inhibitor of activated STAT1 (PIAS1) in lipogenic regulation through SUMOylation-independent suppression of liver X receptors
Y Zhang, Z Gan, P Huang, L Zhou, T Mao, M Shao, X Jiang, Y Chen, H Ying, M Cao, J Li, J Li, WJ Zhang, L Yang, Y Liu
The Journal of biological chemistry 2012
Myelin-derived lipids modulate macrophage activity by liver X receptor activation
JF Bogie, S Timmermans, VA Huynh-Thu, A Irrthum, HJ Smeets, JÅ Gustafsson, KR Steffensen, M Mulder, P Stinissen, N Hellings, JJ Hendriks
PloS one 2012
Molecular mechanisms of estrogen receptors' suppression of lipogenesis in pancreatic β-cells
JP Tiano, F Mauvais-Jarvis
Endocrinology 2012
Extract of Kuding tea prevents high-fat diet-induced metabolic disorders in C57BL/6 mice via liver X receptor (LXR) β antagonism
S Fan, Y Zhang, N Hu, Q Sun, X Ding, G Li, B Zheng, M Gu, F Huang, YQ Sun, Z Zhou, X Lu, C Huang, G Ji
PloS one 2012
Fasting-Induced FGF21 Is Repressed by LXR Activation via Recruitment of an HDAC3 Corepressor Complex in Mice
A Archer, N Venteclef, A Mode, M Pedrelli, C Gabbi, K Clément, P Parini, JÅ Gustafsson, M Korach-André
Molecular Endocrinology 2012
Liver X Receptor Agonist Modulation of Cholesterol Efflux in Mice With Intestine-Specific Deletion of Microsomal Triglyceride Transfer Protein
Y Xie, S Kennedy, R Sidhu, J Luo, DS Ory, NO Davidson
Arteriosclerosis, thrombosis, and vascular biology 2012

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 7 patents
Referenced in 1 Wikipedia pages
112 readers on Mendeley
See more details